ESMO Expert Commentary | Professor Xinxiang Li: Rechallenge with EGFR Inhibitors in ctDNA RAS/BRAF Wild-Type Refractory mCRC Provides New Perspectives for Colorectal Cancer Treatment
Editor's Note:The European Society for Medical Oncology (ESMO) annual meeting in Madrid, Spain has proceeded as scheduled. "Oncology Frontier" has selected key research reported at ESMO 2023 for commentary by…